Xeris Biopharma Holdings Inc (XERS)
R&D Expense Growth
21.93%
Fiscal year · Period ending:
XERS R&D Expense Growth
Latest reported21.93%period ending
Latest reported21.93%period ending
XERS FY R&D Growth (YoY) (0.00% → 21.93%)
Latest values, visible window
High-resolution chart · PNG
XERS r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 21.9288% | |
| 14.4085% | |
| 6.5582% | |
| -16.6693% | |
| 20.2619% | |
| -65.3844% | |
| 48.6643% | |
| 101.5967% | |
| 96.9721% | |
| 0% |